Skip to main content

Table 7 PD-1/PD-L1 expression in tumour-associated lymphocytes

From: The immune checkpoint regulator PD-L1 expression are associated with clinical progression in prostate cancer

Variable

Number

PD-1

PD-L1

Negative

Positive

P

Negative

Positive

P

Age

       

 < 60

5

3

2

0.164

3

2

0.880

 60–69

25

20

5

 

19

6

 

 70–79

38

35

3

 

27

11

 

 > 80

28

25

3

 

21

7

 

PSA

   

0.215

  

0.376

 < 4.0

5

3

2

 

3

2

 

 4–10

3

2

1

 

1

2

 

 10–20

14

12

2

 

11

3

 

 > 20

74

66

8

 

55

19

 

Gleason score

   

0.613

  

0.034

 < 7

5

4

1

 

5

0

 

 7

25

23

2

 

22

3

 

 ≥ 8

66

56

10

 

43

23

 

pT stage

   

0.546

  

0.154

 T1+T2

30

25

5

 

19

11

 

 T3+T4

66

58

8

 

51

15

 

pN stage

   

0.787

  

0.961

 pN0

41

35

6

 

30

11

 

 pN1

55

48

7

 

40

15

 

Grade of risk factors

   

0.186

  

0.661

 Moderate

6

4

2

 

4

2

 

 High

90

79

11

 

66

24

Â